Anika Therapeutics received CE Mark approval for CINGAL® as a medical device to treat knee osteoarthritis (OA) pain. CINGAL joins Anika’s ORTHOVISC® and MONOVISC® products to treat pain associated with knee OA.
EU launch is slated for coming months through a network of existing and new commercial partnerships.
Health Canada approved CINGAL as a medical device to treat knee OA pain in mid-4Q15; the company is working with its distribution partner to finalize commercial launch in 2Q16 and continues pursuit of FDA regulatory approval, where it is assigned for review by the Center for Drug Evaluation and Research.
Source: Anika Therapeutics, Inc.
Anika Therapeutics received CE Mark approval for CINGAL® as a medical device to treat knee osteoarthritis (OA) pain. CINGAL joins Anika's ORTHOVISC® and MONOVISC® products to treat pain associated with knee OA.
EU launch is slated for coming months through a network of existing and new commercial partnerships.
Health Canada approved CINGAL...
Anika Therapeutics received CE Mark approval for CINGAL® as a medical device to treat knee osteoarthritis (OA) pain. CINGAL joins Anika’s ORTHOVISC® and MONOVISC® products to treat pain associated with knee OA.
EU launch is slated for coming months through a network of existing and new commercial partnerships.
Health Canada approved CINGAL as a medical device to treat knee OA pain in mid-4Q15; the company is working with its distribution partner to finalize commercial launch in 2Q16 and continues pursuit of FDA regulatory approval, where it is assigned for review by the Center for Drug Evaluation and Research.
Source: Anika Therapeutics, Inc.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.